Sukamoto Takayuki | New Drug Research Laboratories, Kanebo, Ltd.
スポンサーリンク
概要
New Drug Research Laboratories, Kanebo, Ltd. | 論文
- Inhibitory Effects of the New Anti-platelet Agent KBT-3022 and Its Metabolite on Rabbit Neutrophil Function In Vitro
- Protective Effect of KBT - 3022, a New Cyclooxygenase Inhibitor, in Cerebral Hypoxia and Ischemia
- Inhibitory Effect of KBT-3022, a New Anti-platelet Agent, on Infiltration of Polymorphonuclear Leukocytes Induced by Leukotriene B_4 or Formyl-Methionyl-Leucyl-Phenylalanine in Mice
- Anti-thrombotic Activity of KBT-3022 in Experimental Models of Thrombosis
- Neurochemical Investigation on the Effects of a New Diphenylpiperazine Calcium Antagonist, KB-2796, on the Central Dopaminergic System of Rats.